Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Optical frequency comb based on nonlinear spectral broadening of a phase modulated comb source driven by dual offset locked carriers.

Nagarjun KP, Vikram BS, Prakash R, Singh A, Selvaraja SK, Supradeepa VR.

Opt Lett. 2020 Feb 15;45(4):893-896. doi: 10.1364/OL.381319.

PMID:
32058498
2.

Radiation Biomarkers: Can Small Businesses Drive Accurate Radiation Precision Medicine?

Prasanna PGS, Narayanan D, Zhang K, Rahbar A, Coleman CN, Vikram B.

Radiat Res. 2020 Jan 7. doi: 10.1667/RR15553.1. [Epub ahead of print]

PMID:
31910120
3.

Enhancing Career Paths for Tomorrow's Radiation Oncologists.

Vapiwala N, Thomas CR Jr, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD Jr, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):52-63. doi: 10.1016/j.ijrobp.2019.05.025. Epub 2019 May 22. Review. No abstract available.

PMID:
31128144
4.

National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.

George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, Wu C, Coleman CN, Vikram B, Ahmed MM.

Cancer. 2019 Aug 15;125(16):2732-2746. doi: 10.1002/cncr.32150. Epub 2019 Apr 24. Review.

PMID:
31017664
5.

Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts.

Zakeri K, Narayanan D, Vikram B, Evans G, Coleman CN, Prasanna PGS.

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):188-196. doi: 10.1016/j.ijrobp.2018.12.027. Epub 2018 Dec 21. Review.

PMID:
30583040
6.
7.

Perspectives on potential research benefits from big data efforts in Radiation Oncology.

Vikram B.

Med Phys. 2018 Oct;45(10):e848-e849. doi: 10.1002/mp.13109. Epub 2018 Aug 28. No abstract available.

PMID:
30152535
8.

Advancing Targeted Radionuclide Therapy Through the National Cancer Institute's Small Business Innovation Research Pathway.

Zakeri K, Narayanan D, Evans G, Prasanna P, Buchsbaum JC, Vikram B, Capala J.

J Nucl Med. 2019 Jan;60(1):41-49. doi: 10.2967/jnumed.118.214684. Epub 2018 Jul 20.

9.

The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective.

Press RH, Shu HG, Shim H, Mountz JM, Kurland BF, Wahl RL, Jones EF, Hylton NM, Gerstner ER, Nordstrom RJ, Henderson L, Kurdziel KA, Vikram B, Jacobs MA, Holdhoff M, Taylor E, Jaffray DA, Schwartz LH, Mankoff DA, Kinahan PE, Linden HM, Lambin P, Dilling TJ, Rubin DL, Hadjiiski L, Buatti JM.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1219-1235. doi: 10.1016/j.ijrobp.2018.06.023. Epub 2018 Jun 30. Review.

10.

Toward A variable RBE for proton beam therapy.

Willers H, Allen A, Grosshans D, McMahon SJ, von Neubeck C, Wiese C, Vikram B.

Radiother Oncol. 2018 Jul;128(1):68-75. doi: 10.1016/j.radonc.2018.05.019. Epub 2018 Jun 14. Review.

11.

Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't!

Zakeri K, Coleman CN, Vikram B.

Front Oncol. 2018 Apr 30;8:130. doi: 10.3389/fonc.2018.00130. eCollection 2018. Review.

12.

Reply to Z. Liao et al and R. Rengan et al.

Kong FM, Vikram B.

J Clin Oncol. 2018 Jul 1;36(19):2005-2006. doi: 10.1200/JCO.2018.78.4660. Epub 2018 May 10. No abstract available.

PMID:
29746231
13.

Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.

Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL.

Semin Radiat Oncol. 2018 Apr;28(2):108-113. doi: 10.1016/j.semradonc.2017.12.002.

14.

Accurate, Precision Radiation Medicine: A Meta-Strategy for Impacting Cancer Care, Global Health, and Nuclear Policy and Mitigating Radiation Injury From Necessary Medical Use, Space Exploration, and Potential Terrorism.

Coleman CN, Prasanna PGS, Bernhard EJ, Buchsbaum JC, Ahmed MM, Capala J, Obcemea C, Deye JA, Pistenmma DA, Vikram B, Bernier J, Dosanjh M.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):250-253. doi: 10.1016/j.ijrobp.2018.02.001. No abstract available.

PMID:
29726348
15.

Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint.

Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, Raben D, Mitchell J.

Cancer Res. 2018 May 1;78(9):2166-2170. doi: 10.1158/0008-5472.CAN-17-3760. Epub 2018 Apr 23. No abstract available.

16.

National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.

Haas-Kogan D, Indelicato D, Paganetti H, Esiashvili N, Mahajan A, Yock T, Flampouri S, MacDonald S, Fouladi M, Stephen K, Kalapurakal J, Terezakis S, Kooy H, Grosshans D, Makrigiorgos M, Mishra K, Poussaint TY, Cohen K, Fitzgerald T, Gondi V, Liu A, Michalski J, Mirkovic D, Mohan R, Perkins S, Wong K, Vikram B, Buchsbaum J, Kun L.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):152-168. doi: 10.1016/j.ijrobp.2018.01.013. Review.

17.

Editorial: Data Based Radiation Oncology-Design of Clinical Trials.

Kessel KA, Lee AWM, Bentzen SM, Vikram B, Nüsslin F, Combs SE.

Front Oncol. 2018 Feb 16;8:34. doi: 10.3389/fonc.2018.00034. eCollection 2018. No abstract available.

18.

Research in imaging/biomarkers for precision medicine in lung cancer: National Cancer Institute funding opportunities.

Vikram B.

Transl Lung Cancer Res. 2017 Dec;6(6):615-616. doi: 10.21037/tlcr.2017.09.09. No abstract available.

19.

A Clarion Call for Large-Scale Collaborative Studies of Pediatric Proton Therapy.

Berrington de Gonzalez A, Vikram B, Buchsbaum JC, de Vathaire F, Dörr W, Hass-Kogan D, Langendijk JA, Mahajan A, Newhauser W, Ottolenghi A, Ronckers C, Schulte R, Walsh L, Yock TI, Kleinerman RA.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):980-981. doi: 10.1016/j.ijrobp.2017.03.033. Epub 2017 Jul 10. No abstract available.

PMID:
28721911
20.

Radiation-Therapeutic Agent Clinical Trials: Leveraging Advantages of a National Cancer Institute Programmatic Collaboration.

Takebe N, Ahmed MM, Vikram B, Bernhard EJ, Zwiebel J, Norman Coleman C, Kunos CA.

Semin Radiat Oncol. 2016 Oct;26(4):271-80. doi: 10.1016/j.semradonc.2016.06.005. Epub 2016 Jun 15. Review.

PMID:
27619249
21.

Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.

Ohri N, Dawson LA, Krishnan S, Seong J, Cheng JC, Sarin SK, Kinkhabwala M, Ahmed MM, Vikram B, Coleman CN, Guha C.

J Natl Cancer Inst. 2016 Jul 4;108(9). pii: djw133. doi: 10.1093/jnci/djw133. Print 2016 Sep. Review.

22.

Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data.

Benedict SH, Hoffman K, Martel MK, Abernethy AP, Asher AL, Capala J, Chen RC, Chera B, Couch J, Deye J, Efstathiou JA, Ford E, Fraass BA, Gabriel PE, Huser V, Kavanagh BD, Khuntia D, Marks LB, Mayo C, McNutt T, Miller RS, Moore KL, Prior F, Roelofs E, Rosenstein BS, Sloan J, Theriault A, Vikram B.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):873-879. doi: 10.1016/j.ijrobp.2016.03.006. No abstract available.

23.

Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.

FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, Michalski JM, Rosen MA, Bradley JD, Shankar LK, Laurie F, Cicchetti MG, Moni J, Coleman CN, Deye JA, Capala J, Vikram B.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):404-11. doi: 10.1016/j.ijrobp.2015.10.028. Epub 2015 Oct 24. Review.

24.

How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?

Rosenstein BS, Capala J, Efstathiou JA, Hammerbacher J, Kerns SL, Kong FS, Ostrer H, Prior FW, Vikram B, Wong J, Xiao Y.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):895-904. doi: 10.1016/j.ijrobp.2015.11.009. Epub 2015 Nov 11. No abstract available.

25.

Education and Training Needs in the Radiation Sciences: Problems and Potential Solutions.

Dynlacht JR, Zeman EM, Held KD, Deye J, Vikram B, Joiner MC.

Radiat Res. 2015 Nov;184(5):449-55. doi: 10.1667/RR14199.1. Epub 2015 Oct 19.

PMID:
26479274
26.

Expanding global access to radiotherapy.

Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, Milosevic M, O'Sullivan B, Rodin DL, Rosenblatt E, Van Dyk J, Yap ML, Zubizarreta E, Gospodarowicz M.

Lancet Oncol. 2015 Sep;16(10):1153-86. doi: 10.1016/S1470-2045(15)00222-3. Review.

PMID:
26419354
27.

Global Task Force on Radiotherapy for Cancer Control.

Jaffray DA, Knaul FM, Atun R, Adams C, Barton MB, Baumann M, Lievens Y, Lui TY, Rodin DL, Rosenblatt E, Torode J, Van Dyk J, Vikram B, Gospodarowicz M.

Lancet Oncol. 2015 Sep;16(10):1144-6. doi: 10.1016/S1470-2045(15)00285-5. No abstract available.

PMID:
26419349
28.

Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Prasanna PG, Narayanan D, Hallett K, Bernhard EJ, Ahmed MM, Evans G, Vikram B, Weingarten M, Coleman CN.

Radiat Res. 2015 Sep;184(3):235-48. doi: 10.1667/RR14186.1. Epub 2015 Aug 18.

29.

Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy.

Fahey F, Zukotynski K, Jadvar H, Capala J; organizing committee, contributors, and participants of the second NCI–SNMMI Workshop on Targeted Radionuclide Therapy.

J Nucl Med. 2015 Jul;56(7):1119-29. doi: 10.2967/jnumed.115.159038. Epub 2015 May 21. No abstract available.

30.

Effects of Green Tea on Streptococcus mutans Counts- A Randomised Control Trail.

Neturi RS, R S, B VS, Y SS, T CS, P SK.

J Clin Diagn Res. 2014 Nov;8(11):ZC128-30. doi: 10.7860/JCDR/2014/10963.5211. Epub 2014 Nov 20.

31.

Radiation therapy and the global health agenda.

Jaffray DA, Atun R, Barton M, Baumann M, Gospodarowicz M, Hoskin P, Knaul FM, Lievens Y, Rosenblatt E, Torode J, Van Dyk J, Vikram B; Union for International Cancer Control's Global Task Force on Radiotherapy for Cancer Control.

Clin Oncol (R Coll Radiol). 2015 Feb;27(2):67-9. doi: 10.1016/j.clon.2014.11.025. No abstract available.

PMID:
25575690
32.

The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.

Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, Roth L, Pistenmaa DA, Love RR, Mohiuddin M, Vikram B.

Front Oncol. 2014 Nov 19;4:333. doi: 10.3389/fonc.2014.00333. eCollection 2014. Review.

33.

National Cancer Institute's Cancer Disparities Research Partnership Program: Experience and Lessons Learned.

Wong RS, Vikram B, Govern FS, Petereit DG, Maguire PD, Clarkson MR, Heron DE, Coleman CN.

Front Oncol. 2014 Nov 3;4:303. doi: 10.3389/fonc.2014.00303. eCollection 2014.

34.

Combining targeted agents with modern radiotherapy in soft tissue sarcomas.

Wong P, Houghton P, Kirsch DG, Finkelstein SE, Monjazeb AM, Xu-Welliver M, Dicker AP, Ahmed M, Vikram B, Teicher BA, Coleman CN, Machtay M, Curran WJ, Wang D.

J Natl Cancer Inst. 2014 Oct 18;106(11). pii: dju329. doi: 10.1093/jnci/dju329. Print 2014 Nov. Review.

35.

Human resources for cancer control in uttar pradesh, India: a case study for low and middle income countries.

Daphtary M, Agrawal S, Vikram B.

Front Oncol. 2014 Sep 4;4:237. doi: 10.3389/fonc.2014.00237. eCollection 2014.

36.

Reply by the authors.

Jarow J, Kluetz PG, Lerner SP, Liu K, Sridhara R, Bajorin D, Chang S, Dinney CP, Groshen S, Morton RA, O'Donnell M, Quale DZ, Schoenberg M, Seigne J, Vikram B.

Urology. 2014 Aug;84(2):495-6. doi: 10.1016/j.urology.2014.04.004. No abstract available.

PMID:
25065996
37.

The medical student perspective on global health care in radiation oncology: opportunities, barriers to sustainability, and future directions.

Burkeen J, Coleman CN, Daphtary M, Vikram B.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):492-4. doi: 10.1016/j.ijrobp.2013.10.013. No abstract available.

PMID:
24929160
38.

Radiation-induced brain damage, impact of Michael Robbins' work and the need for predictive biomarkers.

Prasanna PG, Ahmed MM, Stone HB, Vikram B, Mehta MP, Coleman CN.

Int J Radiat Biol. 2014 Sep;90(9):742-52. doi: 10.3109/09553002.2014.925607. Epub 2014 Jun 25. Review.

PMID:
24844376
39.

Harnessing the potential of radiation-induced immune modulation for cancer therapy.

Ahmed MM, Hodge JW, Guha C, Bernhard EJ, Vikram B, Coleman CN.

Cancer Immunol Res. 2013 Nov;1(5):280-4. doi: 10.1158/2326-6066.CIR-13-0141. Review.

40.

Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.

Rosenblatt E, Abdel-Wahab M, El-Gantiry M, Elattar I, Bourque JM, Afiane M, Benjaafar N, Abubaker S, Chansilpa Y, Vikram B, Levendag P.

Radiat Oncol. 2014 Mar 1;9:67. doi: 10.1186/1748-717X-9-67.

41.

Diphtheria Re-emergence: Problems Faced by Developing Countries.

Dandinarasaiah M, Vikram BK, Krishnamurthy N, Chetan AC, Jain A.

Indian J Otolaryngol Head Neck Surg. 2013 Dec;65(4):314-8. doi: 10.1007/s12070-012-0518-5. Epub 2012 Feb 25.

42.

Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging.

Fahey F, Zukotynski K, Capala J, Knight N; Organizing Committee, Contributors, and Participants of NCI/SNMMI Joint Workshop on Targeted Radionuclide Therapy.

J Nucl Med. 2014 Feb;55(2):337-48. doi: 10.2967/jnumed.113.135178. Epub 2014 Jan 6. No abstract available.

43.

Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: report of a Food and Drug Administration and American Urological Association public workshop.

Jarow JP, Lerner SP, Kluetz PG, Liu K, Sridhara R, Bajorin D, Chang S, Dinney CP, Groshen S, Morton RA, O'Donnell M, Quale DZ, Schoenberg M, Seigne J, Vikram B.

Urology. 2014 Feb;83(2):262-4. doi: 10.1016/j.urology.2013.10.030. Epub 2013 Dec 12.

PMID:
24332121
44.

Lessons learned from radiation oncology clinical trials.

Liu FF; workshop participants, Okunieff P, Bernhard EJ, Stone HB, Yoo S, Coleman CN, Vikram B, Brown M, Buatti J, Guha C.

Clin Cancer Res. 2013 Nov 15;19(22):6089-100. doi: 10.1158/1078-0432.CCR-13-1116. Epub 2013 Sep 16. Review.

45.

Opportunities and challenges in the era of molecularly targeted agents and radiation therapy.

Lin SH, George TJ, Ben-Josef E, Bradley J, Choe KS, Edelman MJ, Guha C, Krishnan S, Lawrence TS, Le QT, Lu B, Mehta M, Peereboom D, Sarkaria J, Seong J, Wang D, Welliver MX, Coleman CN, Vikram B, Yoo S, Chung CH; Participants on Workshop for Preclinical and Clinical Development of Radiosensitizers; National Cancer Institute.

J Natl Cancer Inst. 2013 May 15;105(10):686-93. doi: 10.1093/jnci/djt055. Epub 2013 Mar 15.

46.

NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.

Lawrence YR, Vikram B, Dignam JJ, Chakravarti A, Machtay M, Freidlin B, Takebe N, Curran WJ Jr, Bentzen SM, Okunieff P, Coleman CN, Dicker AP.

J Natl Cancer Inst. 2013 Jan 2;105(1):11-24. doi: 10.1093/jnci/djs472. Epub 2012 Dec 10.

47.

Normal tissue protection for improving radiotherapy: Where are the Gaps?

Prasanna PG, Stone HB, Wong RS, Capala J, Bernhard EJ, Vikram B, Coleman CN.

Transl Cancer Res. 2012 Jun;1(1):35-48.

48.

Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.

Bekelman JE, Deye JA, Vikram B, Bentzen SM, Bruner D, Curran WJ Jr, Dignam J, Efstathiou JA, FitzGerald TJ, Hurkmans C, Ibbott GS, Lee JJ, Merchant TE, Michalski J, Palta JR, Simon R, Ten Haken RK, Timmerman R, Tunis S, Coleman CN, Purdy J.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):782-90. doi: 10.1016/j.ijrobp.2011.12.080. Epub 2012 Mar 15.

49.

Role of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in diagnosing metastasis to the pancreas: a tertiary center experience.

Hijioka S, Matsuo K, Mizuno N, Hara K, Mekky MA, Vikram B, Hosoda W, Yatabe Y, Shimizu Y, Kondo S, Tajika M, Niwa Y, Tamada K, Yamao K.

Pancreatology. 2011;11(4):390-8. doi: 10.1159/000330536. Epub 2011 Aug 30.

PMID:
21894056
50.

Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors.

Ryan JL, Krishnan S, Movsas B, Coleman CN, Vikram B, Yoo SS.

Radiat Res. 2011 Nov;176(5):688-91. Epub 2011 Sep 1. No abstract available.

Supplemental Content

Loading ...
Support Center